Estrogen-containing combined hormonal contraceptives are not tied to vascular risk, such as stroke, in women with migraine with and without aura.

FDA Cleared Nerivio® REN Wearable Offers Non-Drug Treatment Option for Millions of People With Migraine as Young as 8. NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- For millions o ...

The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged.

Migraine is the third most common illness in the world, with about 14 percent of the global population experiencing migraine ...

Migraine disease affects millions of Americans, but treatments often cause side effects that hinder sufferers' ability to function.

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine.